This invention relates to therapeutic compounds which are inhibitors of serineproteases, to pharmaceutical compositionsthereof and to their use in the treatment of the human or animal body. Morespecifically, the present invention relates to amethod for the treatment, diagnosis or prognosis of skin diseases comprisingthe administration to a subject in need thereof of atherapeutically effective amount of a Serine protease inhibitor.